placeholder image
S. R. Heller All authors
About
Publications
selected publications
Journal Article
  • Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies
    Diabetes, Obesity & Metabolism. 2021
  • Alogliptin in patients with type 2 diabetes receiving metformin and sulfonylurea therapies in the EXAMINE Trial
    American Journal of Medicine. 2018
  • Average clinician-measured blood pressures and cardiovascular outcomes in patients with type 2 diabetes mellitus and ischemic heart disease in the EXAMINE Trial
    Journal of the American Heart Association. 2018
  • High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial
    Diabetes, Obesity & Metabolism. 2018
  • Total cardiovascular events analysis of the EXAMINE trial in patients with type 2 diabetes and recent acute coronary syndrome
    Clinical Cardiology. 2018
  • Fast-acting insulin aspart improves glycemic control in basal-bolus treatment for type 1 diabetes: results of a 26-week multicenter, active-controlled, treat-to-target, randomized, parallel-group trial (onset 1)
    Diabetes care. 2017
  • Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the EXAMINE trial
    Diabetes, Obesity & Metabolism. 2017
  • Cardiovascular mortality in patients with type 2 diabetes and recent acute coronary syndromes from the EXAMINE Trial
    Diabetes care. 2016
  • Alogliptin after acute coronary syndrome in patients with type 2 diabetes
    New England Journal of Medicine. 2013
  • EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome
    American Heart Journal. 2011
  • Contact
    full name
  • S. R. Heller
  • Quick Info
     
    Collaboration